Option Care Competitors or Alternatives

Option Care's top competitors include Amerita, CareCentrix and ARJ Infusion.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Option Care's company profile

John C. Rademacher

CEO

74/100
5,000 - 10,000
$0
$500M - 1B
1
Option Care's Competitor - Amerita logo

Richard Iriye

President

80/100
500 - 1,000
- -
$25M - 100M
2
Option Care's Competitor - CareCentrix logo

John Driscoll

CEO

90/100
1,000 - 5,000
- -
$1B - 5B
3
Option Care's Competitor - ARJ Infusion logo

Andy Copeland

CEO

86/100
25 - 100
- -
$5M - 25M
4
Option Care's Competitor - Coastal Infusion Services logo

Brandon Migliore

Founder

90/100
25 - 100
- -
$5M - 25M
5
Option Care's Competitor - PruittHealth logo

Neil L. Pruitt Jr

Chairman & CEO

100/100
10,000 - 50,000
- -
$1B - 5B

Option Care VS Amerita

Amerita is a top competitor of Option Care. Amerita is a Private company that was founded in 2006 in Greenwood Village, Colorado. Amerita operates in the Health Care Services industry. Compared to Option Care, Amerita has 7,000 fewer employees.

Option Care VS CareCentrix

CareCentrix is seen as one of Option Care's biggest rivals. CareCentrix was founded in 1996, and is headquartered in Hartford, Connecticut. CareCentrix is in the Health Care Technology industry. CareCentrix generates $1B more revenue vs. Option Care.

Option Care VS ARJ Infusion

ARJ Infusion is seen as one of Option Care's top competitors. ARJ Infusion was founded in Lenexa, Kansas} in 2000. ARJ Infusion competes in the Health Care Services industry. Compared to Option Care, ARJ Infusion generates $485M less revenue.

Frequently Asked Questions about Option Care

  1. Who are Option Care's top competitors?

    Option Care's top 3 competitors are Amerita, CareCentrix, ARJ Infusion.
  2. Who is similar to Option Care?

    Amerita is the most similar to Option Care. CareCentrix and ARJ Infusion are also similar to Option Care.
  1. Are Option Care and Amerita competitors?

    Yes, Amerita is one of Option Care’s top competitors.